Table 3. Multinomial regression analysis using CKD as predictor variable with outcome of “new” or “worsening” monofilament insensitivity.
Monofilament sensitivity | Unadjusted analysis OR and 95% CI | Adjusted analysis OR and 95% CI |
---|---|---|
Between years 2000–01 and 2007–08 | CKD vs non-CKD | |
Participants who “maintained normal function” as reference category for outcome of “new” monofilament insensitivity # | ||
Maintained normal function (N = 388) | Reference category | |
New light touch insensitivity (N = 183) | 1.41 (0.85–2.35) | 1.51 (0.89–2.54) |
New standard touch insensitivity (N = 64) | 1.62 (0.79–3.39) | 1.47 (0.70–3.08) |
Participants who “maintained function” as reference category for outcome of “worsening sensitivity” and “improving sensitivity” $ | ||
Maintained function (light touch insensitivity) (N = 136) | Reference category | |
Worsened to standard touch insensitivity (N = 89) | 1.79 (0.92–3.51) | 2.09 (1.03–4.29) |
Improved to normal sensitivity (N = 175) | 1.42 (0.78–2.56) | 1.64 (0.86–3.13) |
# Forward stepwise model. Only participants with normal sensitivity at initial visit included
$ Forward stepwise model. Final model adjusted for age, gender, race, smoking status at year 3 and peripheral arterial disease. Reverse confounding variable for outcome of “worsened to standard touch insensitivity”: smoking and peripheral arterial disease